AMAG Pharmaceuticals director just picked up 192 shares


James R Sulat, a director of AMAG Pharmaceuticals, recently acquired 192 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on April 14, 2014. Sulat now owns 192 shares of the company. Sulat operates out of Waltham, MA. Some additional info was provided as follows:

Each restricted stock unit represents a contingent right to receive one share of common stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of common stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended and Restated 2007 Equity Incentive Plan (the "Plan") that vests in full on May 1, 2014; however, delivery of the shares is deferred until the earlier of (a) thr ee years from the date of grant and (b) the date of the director's separation from service to the Issuer. Not applicable. Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in twenty-four equal monthly installments over two years from the date of grant. Grant of stock option pursuant to the Plan. This option vests and becomes exercisable in full on May 1, 2014.

The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here. AMAG Pharmaceuticals next reports earnings on April 21, 2014.

To receive a free e-mail notification whenever AMAG Pharmaceuticals makes a similar move, sign up!

Other recent filings from the company include the following:

AMAG: Results Of Operations And Financial Condition - Oct. 21, 2014
Amag Pharmaceuticals To Acquire Lumara Health Maternal Health Business - Sept. 29, 2014
Registration of securities [Section 12(b)] - Sept. 29, 2014

   Auto Refresh

Feedback